Departamento de Bioquímica, Instituto Biofisika (UPV/EHU, CSIC), Universidad del País Vasco, Apdo.644, 48080 Bilbao, Spain.
Int J Mol Sci. 2018 Nov 1;19(11):3426. doi: 10.3390/ijms19113426.
Cholesterol is an essential component of cell barrier formation and signaling transduction involved in many essential physiologic processes. For this reason, cholesterol metabolism must be tightly controlled. Cell cholesterol is mainly acquired from two sources: Dietary cholesterol, which is absorbed in the intestine and, intracellularly synthesized cholesterol that is mainly synthesized in the liver. Once acquired, both are delivered to peripheral tissues in a lipoprotein dependent mechanism. Malfunctioning of cholesterol metabolism is caused by multiple hereditary diseases, including Familial Hypercholesterolemia, Sitosterolemia Type C and Niemann-Pick Type C1. Of these, familial hypercholesterolemia (FH) is a common inherited autosomal co-dominant disorder characterized by high plasma cholesterol levels. Its frequency is estimated to be 1:200 and, if untreated, increases the risk of premature cardiovascular disease. This review aims to summarize the current knowledge on cholesterol metabolism and the relation of FH to cholesterol homeostasis with special focus on the genetics, diagnosis and treatment.
胆固醇是细胞屏障形成和信号转导的重要组成部分,参与许多重要的生理过程。因此,胆固醇代谢必须受到严格控制。细胞胆固醇主要来自两个来源:饮食胆固醇,它在肠道中被吸收,以及细胞内合成的胆固醇,主要在肝脏中合成。一旦获得,两者都通过脂蛋白依赖机制被输送到外周组织。胆固醇代谢的功能障碍是由多种遗传性疾病引起的,包括家族性高胆固醇血症、甾醇血症 C 型和尼曼-皮克 C1 型。其中,家族性高胆固醇血症(FH)是一种常见的常染色体共显性遗传疾病,其特征是血浆胆固醇水平升高。其频率估计为 1:200,如果不治疗,会增加早发性心血管疾病的风险。本综述旨在总结胆固醇代谢的最新知识以及 FH 与胆固醇动态平衡的关系,特别关注遗传学、诊断和治疗。